Cambrian BioPharma Inc
CIK 1797409 · last filed 2026-06-01
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$1.69M
Companies
1
Total Filings
58
Lifetime Open-Market Net
$3.37M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| SNSE | 10%+ Owner | 130,142 | $13.00 | $1.69M | $3.37M | 58 | 2026-06-01 |
Recent Filings · Page 5 of 6
58 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2021-04-02 | SNSE | Buy (P) | +1,000 | $14.0K | EDGAR |
| 2021-03-31 | SNSE | Buy (P) | +2,000 | $24.0K | EDGAR |
| 2021-03-25 | SNSE | Buy (P) | +3,750 | $53.0K | EDGAR |
| 2021-03-24 | SNSE | Buy (P) | +10,000 | $143.4K | EDGAR |
| 2021-03-23 | SNSE | Buy (P) | +2,183 | $32.8K | EDGAR |
| 2021-03-19 | SNSE | Buy (P) | +817 | $12.5K | EDGAR |
| 2021-03-10 | SNSE | Buy (P) | +1,000 | $15.2K | EDGAR |
| 2021-03-08 | SNSE | Buy (P) | +8,000 | $110.0K | EDGAR |
| 2021-03-05 | SNSE | Buy (P) | +5,000 | $75.8K | EDGAR |
| 2021-03-03 | SNSE | Buy (P) | +3,000 | $48.8K | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.